The size of the bioabsorbable stents market in Latin America is predicted to hit USD 928.55 million by 2027 from USD 147.39 million in 2022, at a CAGR of 44.5%.
An increase in cardiovascular surgeries is a result of the rise in the danger of cardiovascular issues among the all-inclusive community encountering obesity. As per WHO reports, cardiovascular issues are the main reason for death than any other medical issues, it is estimated that by 2030 more than 23 million individuals may die as a result of Cardiovascular infections. Therefore, the aging population and an increase in cardiovascular diseases are the key driving components for the advancement of the market. Positive consequences of surgeries with bioabsorbable stents and post-surgery reports moreover speak to the change of market.
However, there are various managerial, mechanical, safety-practicality, besides cost-related issues which ought to be tackled before accomplishing its extreme limit.
This research report on the LATAM Bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.
By Absorption Rate:
By End User:
Prominent companies leading the LATAM Bioabsorbable stents market are Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A, Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT, Xenogenics Corporation
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]